Paddock Labs Attorney Fee Bid Nixed

By Ben James (December 20, 2007, 12:00 AM EST) -- After having delayed a ruling on defendant Paddock Laboratories Inc.'s motion for attorneys' fees and costs while Schwartz Pharma AG appealed an October 2006 decision to grant summary judgment to Paddock in a patent suit over the hypertension drug Univasc, the district court has denied Paddock's bid for fees, and advised both sides to move on....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!